000			01720 a2200493 4500
005			20250515145012.0
264		0	_c20090123
008			200901s 0 0 eng d
022			_a0966-8519
040			_aNLM _beng _cNLM
100	1		_aShannon, Muriel S
245	0	0	_aAnticoagulant management of pregnancy following heart valve replacement in the United Kingdom, 1986-2002. _h[electronic resource]
260			_bThe Journal of heart valve disease _cSep 2008
300			_a526-32 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAbortion, Spontaneous _xmortality
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aBioprosthesis
650	0	4	_aCause of Death
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFetal Diseases _xchemically induced
650	0	4	_aHeart Failure _xmortality
650	0	4	_aHeart Valve Prosthesis Implantation
650	0	4	_aHeparin _xadverse effects
650	0	4	_aHeparin, Low-Molecular-Weight _xadverse effects
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aPostoperative Complications _xdrug therapy
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications, Cardiovascular _xdrug therapy
650	0	4	_aPregnancy Outcome
650	0	4	_aRisk Factors
650	0	4	_aUnited Kingdom
650	0	4	_aWarfarin _xadverse effects
700	1		_aEdwards, Maria-Benedicta
700	1		_aLong, Fiona
700	1		_aTaylor, Kenneth M
700	1		_aBagger, Jans Peder
700	1		_aDe Swiet, Michael
773	0		_tThe Journal of heart valve disease _gvol. 17 _gno. 5 _gp. 526-32
999			_c18441648 _d18441648